ArticleFrontiers in immunology2025

Dupilumab treatment has no effect on the nasal microbiome in patients with NSAID-exacerbated respiratory disease: a longitudinal pilot study.

Tina Bartosik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.